ABEO logo

ABEO
Abeona Therapeutics Inc

11,008
Mkt Cap
$324.04M
Volume
362,604.00
52W High
$7.54
52W Low
$4.00
PE Ratio
5.70
ABEO Fundamentals
Price
$5.70
Prev Close
$5.68
Open
$5.81
50D MA
$5.08
Beta
0.71
Avg. Volume
976,586.51
EPS (Annual)
$1.01
P/B
1.96
Rev/Employee
$25,752.21
$182.10
Loading...
Loading...
News
all
press releases
Abeona Therapeutics (ABEO) to Release Quarterly Earnings on Wednesday
Abeona Therapeutics (NASDAQ:ABEO) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 13. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-13-abeona-therapeutics-inc-stock...
MarketBeat·7d ago
News Placeholder
More News
News Placeholder
Abeona Therapeutics Inc. (NASDAQ:ABEO) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of Abeona Therapeutics Inc. (NASDAQ:ABEO - Get Free Report) have been given a consensus rating of "Moderate Buy" by the five brokerages that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating and four have assigned a buy rating to the c...
MarketBeat·9d ago
News Placeholder
2,000,000 Shares in Abeona Therapeutics Inc. $ABEO Purchased by AIGH Capital Management LLC
AIGH Capital Management LLC purchased a new position in Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 2,000,000 shares of the biopharmaceutical compa...
MarketBeat·11d ago
News Placeholder
Abeona Therapeutics (NASDAQ:ABEO) Share Price Crosses Above 50 Day Moving Average - Here's What Happened
Abeona Therapeutics (NASDAQ:ABEO) Stock Price Crosses Above Fifty Day Moving Average - What's Next...
MarketBeat·15d ago
News Placeholder
Aberdeen Group plc Makes New $3.25 Million Investment in Abeona Therapeutics Inc. $ABEO
Aberdeen Group plc acquired a new position in shares of Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange...
MarketBeat·1mo ago
News Placeholder
HC Wainwright Issues Pessimistic Outlook for ABEO Earnings
Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) - Equities researchers at HC Wainwright decreased their Q1 2026 EPS estimates for Abeona Therapeutics in a report released on Thursday, March 19th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceutical company will post ear...
MarketBeat·2mo ago
News Placeholder
Abeona Therapeutics (NASDAQ:ABEO) Earns Buy Rating from HC Wainwright
HC Wainwright reiterated a "buy" rating and issued a $20.00 price target on shares of Abeona Therapeutics in a research report on Thursday...
MarketBeat·2mo ago
News Placeholder
Abeona Therapeutics Q4 Earnings Call Highlights
Abeona Therapeutics (NASDAQ:ABEO) executives said the company is seeing growing patient demand for ZEVASKYN, an autologous cell-based gene therapy approved in April 2025 for adults and pediatric...
MarketBeat·2mo ago
News Placeholder
Abeona Therapeutics (NASDAQ:ABEO) Releases Quarterly Earnings Results, Misses Expectations By $0.01 EPS
Abeona Therapeutics (NASDAQ:ABEO - Get Free Report) issued its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.34) EPS for the quarter, missing analysts' consensus...
MarketBeat·2mo ago
News Placeholder
Abeona Therapeutics Inc. $ABEO Shares Sold by Boone Capital Management LLC
Boone Capital Management LLC decreased its holdings in shares of Abeona Therapeutics Inc. (NASDAQ:ABEO - Free Report) by 59.9% during the third quarter, according to its most recent disclosure with...
MarketBeat·2mo ago
<
1
2
...
>

Latest ABEO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.